Roslin Cells creates two commercially focused subsidiaries: Roslin Cell Therapies & Roslin

Released: Monday 11th January 2016

Roslin Cells Ltd., the Edinburgh and Cambridge based spin out from the world renowned Roslin Institute, announced today that it has established two subsidiary companies to accelerate the expansion of its commercial operations. Roslin Cell Therapies will carry forward its process development and manufacture of cell therapies for clinical trial. Roslin Cell Sciences will focus on the production and use of human induced Pluripotent Stem Cells (iPSCs) for drug discovery.

Click here for the full press release



View all News